Global CRISPR Gene Editing Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The CRISPR Gene Editing Market Over The Five-Year Period 2025–2029?

The crispr gene editing market has seen significant expansion in recent years. It is anticipated to expand from $2.26 billion in 2024 to $2.88 billion in 2025, reflecting a compound annual growth rate (CAGR) of 27.1%. This historical growth can be attributed to several factors including a heightened demand for genome editing technologies, an increase in government funding, a rise in cancer cases, a greater prevalence of chronic diseases, enhanced awareness regarding CRISPR technology, and improvements in healthcare infrastructure.

The crispr gene editing market size is anticipated to expand significantly in the near future, projected to reach $6.99 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 24.9%. This expansion throughout the forecast period is primarily driven by the increasing occurrence of genetic disorders, a heightened focus on precision medicine, rising investments in CRISPR research and development, an aging global population, and the growing importance of gene therapy procedures. Noteworthy trends during this time include continuous advancements in gene editing technology, an increase in research studies, progress in drug discovery and development, innovative delivery methods, and the integration of CRISPR-edited agriculture.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp

Which Industry Drivers Are Expected To Accelerate The CRISPR Gene Editing Market From 2025 To 2029?

The rising occurrence of genetic disorders is projected to boost the expansion of the CRISPR gene editing market moving forward. A genetic disorder represents a health condition stemming from genome irregularities, encompassing mutations within a single gene (monogenic), multiple genes (polygenic), or chromosomal defects. The incidence of genetic disorders is on the rise, attributed to genetic mutations, an aging demographic, and marriages between relatives. CRISPR gene editing provides substantial assistance in handling genetic disorders through accurate and focused alterations to DNA. Moreover, researchers utilize CRISPR to pinpoint and rectify specific mutations that cause genetic disorders, thereby restoring normal bodily functions and mitigating disease manifestations, as observed in ailments like cystic fibrosis and sickle cell anemia. For example, in July 2022, data from the Cystic Fibrosis (CF) Foundation, a US-based non-profit entity, indicated a surge in individuals afflicted with cystic fibrosis. In 2022, nearly 40,000 children and adults in the United States were impacted by cystic fibrosis, and globally, more than 105,000 people have received this diagnosis. Consequently, the growing prevalence of genetic disorders is fueling the expansion of the CRISPR gene editing market.

Which Key Segments Fueling The CRISPR Gene Editing Market?

The crispr gene editingmarket covered in this report is segmented –

1) By Type: CRISPR-Associated Nuclease (Cas Nuclease); Guide Ribonucleic Acid (RNA); Deoxyribonucleic Acid (DNA) Ligase; Restriction Endonuclease; Other Types

2) By Services: Design Tools; Plasmid And Vector; CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA); Delivery System Products; Other Services

3) By Technology: CRISPR Or Cas9; Zinc Finger Nucleases; Other Technologies

4) By Application: Agricultural; Biomedical; Industrial; Genome Engineering; Disease Models; Functional Genomics; Other Applications

5) By End User: Academic Institutes And Research Centers; Biotechnology Companies; Contract Research Organizations (CROs); Pharmaceutical And Biopharmaceutical Companies

Subsegments:

1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9; Cas12; Cas13; Other Cas Nucleases

2) By Guide Ribonucleic Acid (RNA): Single-guide RNA (sgRNA); Dual-guide RNA; Synthetic Guide RNA

3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase; E. coli DNA Ligase; Other DNA Ligases

4) By Restriction Endonuclease: Type II Restriction Enzymes; Type I And III Restriction Enzymes; Other Restriction Enzymes

5) By Other Types: CRISPR Delivery Systems; CRISPR Plasmids; CRISPR-Based Diagnostic Tools

What Long-Term Trends Will Shape The Future Growth Of The CRISPR Gene Editing Industry?

Major companies operating in the CRISPR gene editing market are focusing on developing innovative products such as gene therapy to reach larger customer bases, increase sales, and boost revenue. Gene therapy is a medical technique that utilizes genes to treat, prevent, or cure various diseases and disorders. For instance, in December 2023, the US Food and Drug Administration (FDA), a US-based federal agency, approved Casgevy, a cell-based gene therapy, for the treatment of sickle cell disease. Casgevy therapy leverages CRISPR/Cas9, a type of genome editing technology, to modify hematopoietic stem cells.

Who Are The Key Multinational Companies Dominating The CRISPR Gene Editing Market?

Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The CRISPR Gene Editing Market?

North America was the largest region in the CRISPR gene editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The CRISPR Gene Editing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15549&type=smp

Browse Through More Reports Similar to the Global CRISPR Gene Editing Market 2025, By The Business Research Company

Crispr And Cas Gene Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Crispr Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

Gene Editing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795